Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database

Seer Database ◽

Lymph Node Positive ◽

Breast cancer-specific survival in >4,600 patients with lymph node-positive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene recurrence score® (RS) results in the SEER registries

Annals of Oncology ◽

10.1093/annonc/mdw364.07 ◽

2016 ◽

Vol 27 ◽

pp. vi45 ◽

Cited By ~ 2

Author(s):

D.P. Miller ◽

M. Roberts ◽

V.I. Petkov ◽

S. Shak ◽

N. Howlader ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Node Positive ◽

Lymph Node Positive

Abstract P5-15-01: Breast cancer specific survival in 38,568 patients with node negative hormone receptor positive invasive breast cancer and oncotype DX recurrence score results in the SEER database

10.1158/1538-7445.sabcs15-p5-15-01 ◽

2016 ◽

Cited By ~ 12

Author(s):

S Shak ◽

VI Petkov ◽

DP Miller ◽

N Howlader ◽

N Gliner ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Seer Database ◽

Node Negative ◽

Breast cancer specific survival in patients with node-positive hormone receptor positive invasive breast cancer and Oncotype DX recurrence score results in the SEER database.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.6575 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 6575-6575

Author(s):

Megan Roberts ◽

Valentina I. Petkov ◽

Dave P. Miller ◽

Steven Shak ◽

Nadia Howlader ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Seer Database ◽

Breast cancer-specific survival in 6,768 patients with lymph nodepositive (LN+) hormone receptor-positive (HR+) invasive breast cancer (BC) and 21-gene Recurrence Score® (RS) results in the SEER registries

The Breast ◽

10.1016/s0960-9776(17)30311-9 ◽

2017 ◽

Vol 32 ◽

pp. S97-S98

Author(s):

S. Shak ◽

M. Roberts ◽

V.I. Petkov ◽

D.P. Miller ◽

N. Howlader ◽

...

Keyword(s):

Breast Cancer ◽

Invasive Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Hormone Receptor Positive

Evaluation of Prognosis in Hormone Receptor–Positive/HER2-Negative and Lymph Node–Negative Breast Cancer With Low Oncotype DX Recurrence Score

Clinical Breast Cancer ◽

10.1016/j.clbc.2017.12.006 ◽

2018 ◽

Vol 18 (5) ◽

pp. 347-352 ◽

Cited By ~ 2

Author(s):

Jane Meisel ◽

Chao Zhang ◽

Cameron Neely ◽

Pia Mendoza ◽

Shuo You ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Hormone Receptor ◽

Recurrence Score ◽

Oncotype Dx ◽

Node Negative ◽

Node Negative Breast Cancer ◽

The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)

BMC Cancer ◽

10.1186/s12885-018-4331-8 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 6

Author(s):

Frédérique Penault-Llorca ◽

Thomas Filleron ◽

Bernard Asselain ◽

Frederick L. Baehner ◽

Pierre Fumoleau ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Cancer Patients ◽

Hormone Receptor ◽

Recurrence Score ◽

Distant Recurrence ◽

Breast Cancer Patients ◽

Lymph Node Positive ◽

Positive Breast Cancer

Abstract PS4-27: A prospective multicenter study evaluating the impact of the 21-Gene Breast Recurrence Score®upon physician treatment decision and cost in lymph node-positive breast cancer patients in Quebec

10.1158/1538-7445.sabcs20-ps4-27 ◽

2021 ◽

Author(s):

Saima Hassan ◽

Rami Younan ◽

Erica Patocskai ◽

Louise Provencher ◽

Brigitte Poirier ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Recurrence Score ◽

Treatment Decision ◽

Breast Cancer Patients ◽

Prospective Multicenter Study ◽

Lymph Node Positive ◽

The Impact ◽

Breast Recurrence ◽

Positive Breast Cancer

Abstract P5-08-02: Real-life analysis evaluating 1594 N0/Nmic breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score result: 5-year KM estimate for breast cancer specific survival with recurrence score results ≤30 is >98%

10.1158/1538-7445.sabcs15-p5-08-02 ◽

2016 ◽

Cited By ~ 11

Author(s):

SM Stemmer ◽

M Steiner ◽

S Rizel ◽

L Soussan-Gutman ◽

DB Geffen ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Real Life ◽

Recurrence Score ◽

Treatment Decisions ◽

Breast Cancer Patients ◽

Life Analysis ◽

Score Result

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.00667 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 2

Author(s):

Mi Jeong Kwon ◽

Jeong Eon Lee ◽

Joon Jeong ◽

Sang Uk Woo ◽

Jinil Han ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Hormone Receptor ◽

Recurrence Score ◽

Risk Classification ◽

Oncotype Dx ◽

Asian Women ◽

Effect of Radiation on Breast Cancer Specific Survival for Elderly Women With Early Stage (T1N0 ER+) Breast Cancer: Review of the SEER Database

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.638 ◽

2012 ◽

Vol 84 (3) ◽

pp. S246

Author(s):

A. Surapaneni ◽

S. Sura ◽

J. Rineer ◽

D. Schwartz ◽

M. Rotman ◽

...

Keyword(s):

Breast Cancer ◽

Elderly Women ◽

Early Stage ◽

Seer Database ◽

Cancer Review